These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 15773308)

  • 21. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
    Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
    Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBV positivity in primary cutaneous large B-cell lymphoma with immunophenotypic features of leg type: an isolated incident or something more significant?
    Gaitonde S; Kavuri S; Alagiozian-Angelova V; Peace D; Worobec S
    Acta Oncol; 2008; 47(3):461-4. PubMed ID: 17896194
    [No Abstract]   [Full Text] [Related]  

  • 23. Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
    Mochida A; Gotoh E; Senpuku H; Harada S; Kitamura R; Takahashi T; Yanagi K
    Arch Virol; 2005 Oct; 150(10):2139-50. PubMed ID: 15986178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
    Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
    Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
    Niller HH; Wolf H; Minarovits J
    Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner.
    Kim YS; Park GB; Choi YM; Kwon OS; Song HK; Kang JS; Kim YI; Lee WJ; Hur DY
    Hum Immunol; 2006 Oct; 67(10):795-807. PubMed ID: 17055356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
    J Surg Res; 2009 May; 153(1):156-61. PubMed ID: 18486150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immortalization as an endpoint in studies on malignant transformation.
    Simons JW; Bols BL; Naaktgeboren JM
    Prog Clin Biol Res; 1990; 340D():207-17. PubMed ID: 2196580
    [No Abstract]   [Full Text] [Related]  

  • 29. Conserved cell cycle regulatory properties within the amino terminal domain of the Epstein-Barr virus nuclear antigen 3C.
    Sharma N; Knight JS; Robertson ES
    Virology; 2006 Mar; 346(2):379-84. PubMed ID: 16364389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The number of dysfunctional telomeres in a cell: one amplifies; more than one translocate.
    Tusell L; Soler D; Agostini M; Pampalona J; Genescà A
    Cytogenet Genome Res; 2008; 122(3-4):315-25. PubMed ID: 19188701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomere instability and cancer.
    Londoño-Vallejo JA
    Biochimie; 2008 Jan; 90(1):73-82. PubMed ID: 17728038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and genotypic characteristics of new euploid-diploid lymphoblastoid B cell lines EBV+, normal human bone marrow derived, spontaneously overgrown in vitro.
    Bertolini L; Aebischer ML; Ameglio F; Angeloni A; Delaroche I; Faggioni A; Fruscalzo A; Gorini G; Serafino A; Starace G; Tabilio A
    J Virol Methods; 2005 Jun; 126(1-2):91-100. PubMed ID: 15847924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus and the germinal center B cells.
    Khan G
    Exp Hematol; 2006 Jun; 34(6):695-6. PubMed ID: 16728272
    [No Abstract]   [Full Text] [Related]  

  • 34. EBV genes and B cell proliferation.
    Manet E; Bourillot PY; Waltzer L; Sergeant A
    Crit Rev Oncol Hematol; 1998 Aug; 28(2):129-37. PubMed ID: 9768348
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular insights to cellular mortality and immortalization.
    Kaul SC; Mitsui Y; Wadhwa R
    Indian J Exp Biol; 1998 Apr; 36(4):345-52. PubMed ID: 9717442
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mechanism of immortalization and tumorigenesis by EBV: overturn of the established theory].
    Sugimoto M; Ide T; Furuichi Y
    Tanpakushitsu Kakusan Koso; 2005 Mar; 50(3):283-8. PubMed ID: 15773308
    [No Abstract]   [Full Text] [Related]  

  • 37. Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability.
    Yamashita Y; Tsurumi T; Mori N; Kiyono T
    Pathol Int; 2006 Nov; 56(11):659-67. PubMed ID: 17040288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of innate immunity by the leukotriene B 4 inhibits EBV induced B-cell transformation in cord-blood derived mononuclear cultures.
    Klein E; Liu A; Claesson HE
    Immunol Lett; 2008 Mar; 116(2):174-7. PubMed ID: 18241933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation.
    Wu Y; Maruo S; Yajima M; Kanda T; Takada K
    J Virol; 2007 Oct; 81(20):11236-45. PubMed ID: 17686859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.